Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan 20;21(2):679.
doi: 10.3390/ijms21020679.

Review of Alterations in Perlecan-Associated Vascular Risk Factors in Dementia

Amanda L Trout  1 , Ibolya Rutkai  2   3 , Ifechukwude J Biose  2 , Gregory J Bix  2   3
Affiliations
Review

Review of Alterations in Perlecan-Associated Vascular Risk Factors in Dementia

Amanda L Trout et al. Int J Mol Sci. .

Abstract

Perlecan is a heparan sulfate proteoglycan protein in the extracellular matrix that structurally and biochemically supports the cerebrovasculature by dynamically responding to changes in cerebral blood flow. These changes in perlecan expression seem to be contradictory, ranging from neuroprotective and angiogenic to thrombotic and linked to lipid retention. This review investigates perlecan's influence on risk factors such as diabetes, hypertension, and amyloid that effect Vascular contributions to Cognitive Impairment and Dementia (VCID). VCID, a comorbidity with diverse etiology in sporadic Alzheimer's disease (AD), is thought to be a major factor that drives the overall clinical burden of dementia. Accordingly, changes in perlecan expression and distribution in response to VCID appears to be injury, risk factor, location, sex, age, and perlecan domain dependent. While great effort has been made to understand the role of perlecan in VCID, additional studies are needed to increase our understanding of perlecan's role in health and in cerebrovascular disease.

Keywords: VCID; and dementia; basement membrane; extracellular matrix; perlecan; vascular risk factors.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no conflict of interest exists.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Hallmann R., Zhang X., Di Russo J., Li L., Song J., Hannocks M.J., Sorokin L. The regulation of immune cell trafficking by the extracellular matrix. Curr. Opin. Cell Biol. 2015;36:54–61. doi: 10.1016/j.ceb.2015.06.006. - DOI - PubMed
    1. Kalluri R. Basement membranes: Structure, assembly and role in tumour angiogenesis. Nat. Rev. Cancer. 2003;3:422–433. doi: 10.1038/nrc1094. - DOI - PubMed
    1. Xu J., Shi G.P. Vascular wall extracellular matrix proteins and vascular diseases. Biochim. Biophys. Acta. 2014;1842:2106–2119. doi: 10.1016/j.bbadis.2014.07.008. - DOI - PMC - PubMed
    1. Engelhardt B., Sorokin L. The blood-brain and the blood-cerebrospinal fluid barriers: Function and dysfunction. Semin. Immunopathol. 2009;31:497–511. doi: 10.1007/s00281-009-0177-0. - DOI - PubMed
    1. Timpl R. Structure and biological activity of basement membrane proteins. Eur. J. Biochem. 1989;180:487–502. doi: 10.1111/j.1432-1033.1989.tb14673.x. - DOI - PubMed

MeSH terms